Dr Gina M Divenuti, MD | |
250 Pleasant St, Concord, NH 03301-7559 | |
(603) 622-6484 | |
(603) 622-7438 |
Full Name | Dr Gina M Divenuti |
---|---|
Gender | Female |
Speciality | Medical Oncology |
Experience | 27 Years |
Location | 250 Pleasant St, Concord, New Hampshire |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912958703 | NPI | - | NPPES |
30203690 | Medicaid | NH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 11904 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Concord Regional Vna | Concord, NH | Home health agency |
Concord Regional Vna - Hospice | Concord, NH | Hospice |
Concord Hospital | Concord, NH | Hospital |
Elliot Hospital | Manchester, NH | Hospital |
Lakes Region General Hospital | Laconia, NH | Hospital |
Franklin Regional Hospital | Franklin, NH | Hospital |
Catholic Medical Center | Manchester, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Elliot Professional Services | 6103727920 | 304 |
New Hampshire Oncology-hematology Pa | 0143290759 | 11 |
News Archive
Hannah Brückner, assistant professor of sociology at Yale University and Peter Bearman, professor of sociology at Columbia University, in new research say young adults who make virginity pledges as adolescents are just as likely to be infected with sexually transmitted diseases as those who do not take virginity pledges, and that virginity pledges may even encourage higher risk sexual behavior.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
Entity Name | Elliot Professional Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285627935 PECOS PAC ID: 6103727920 Enrollment ID: O20040115000634 |
News Archive
Hannah Brückner, assistant professor of sociology at Yale University and Peter Bearman, professor of sociology at Columbia University, in new research say young adults who make virginity pledges as adolescents are just as likely to be infected with sexually transmitted diseases as those who do not take virginity pledges, and that virginity pledges may even encourage higher risk sexual behavior.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
Entity Name | Lrghealthcare |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700976032 PECOS PAC ID: 8820908189 Enrollment ID: O20040303000982 |
News Archive
Hannah Brückner, assistant professor of sociology at Yale University and Peter Bearman, professor of sociology at Columbia University, in new research say young adults who make virginity pledges as adolescents are just as likely to be infected with sexually transmitted diseases as those who do not take virginity pledges, and that virginity pledges may even encourage higher risk sexual behavior.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
Entity Name | New Hampshire Oncology-hematology Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467485870 PECOS PAC ID: 0143290759 Enrollment ID: O20040730000144 |
News Archive
Hannah Brückner, assistant professor of sociology at Yale University and Peter Bearman, professor of sociology at Columbia University, in new research say young adults who make virginity pledges as adolescents are just as likely to be infected with sexually transmitted diseases as those who do not take virginity pledges, and that virginity pledges may even encourage higher risk sexual behavior.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gina M Divenuti, MD 200 Technology Dr, Hooksett, NH 03106-2504 Ph: (603) 622-6484 | Dr Gina M Divenuti, MD 250 Pleasant St, Concord, NH 03301-7559 Ph: (603) 622-6484 |
News Archive
Hannah Brückner, assistant professor of sociology at Yale University and Peter Bearman, professor of sociology at Columbia University, in new research say young adults who make virginity pledges as adolescents are just as likely to be infected with sexually transmitted diseases as those who do not take virginity pledges, and that virginity pledges may even encourage higher risk sexual behavior.
It's a new day for health insurance companies. As the Affordable Care Act forces an industry shift towards consumerism, individuals are becoming more involved in their own health care decisions and insurers are becoming more involved in their members' lives.
The discovery of a specific pattern of gene expression linked to multiple-drug resistance of leukemic cells is giving researchers crucial information into why standard therapies fail to cure some children with acute lymphoblastic leukemia (ALL). This finding, from investigators at St. Jude Children's Research Hospital, could lead to development of drugs that would overcome that resistance.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
Patrick Cassell, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6994 | |
Dr. Michael A Ferguson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Clayton Theron Jones, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. David Scott Johnson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Primary Care, Concord, NH 03301 Phone: 603-226-2200 | |
Frederick M Briccetti, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, New Hampshire Oncology Hematology Pa, Concord, NH 03301 Phone: 603-224-2556 Fax: 603-226-5821 | |
Dr. Patrick Magnus, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Celia Ann Englander, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 281 N State St, Concord, NH 03301 Phone: 603-271-6064 |